Skip to main content
. 2014 Oct;134(4):e935–e944. doi: 10.1542/peds.2014-0428

TABLE 1.

Baseline and Follow-up Characteristics of Non-ADHD Controls and ADHD Cases; ADHD Cases Separately by Treatment Status

Characteristic ADHD Case Status Pa ADHD Cases Treated With Stimulants for ≥3 Monthsb Pa
Non-ADHD Controls (N = 394) ADHD Cases (N = 243) Yes (N = 171) No (N = 65)
Baseline
 Gender, n (%) .88 .027
  Male 286 (72.6) 175 (72.0) 130 (76.0) 40 (61.5)
  Female 108 (27.4) 68 (28.0) 41 (24.0) 25 (38.5)
 Birth length (cm), mean (SD) 51.8 (2.8) 51.7 (2.9) .73 51.7 (3.0) 51.8 (2.7) .83
 Birth wt (g), mean (SD) 3522 (560) 3456 (566) .15 3449 (547) 3472 (619) .78
 Maternal age at subject’s birth, mean (SD) 26.4 (4.7) 26.1 (4.9) .47 26.2 (4.7) 26.1 (5.4) .87
 Maternal education at subject’s birth, n (%) .011 .29
  Not available, n 42 19 15 4
  Less than high school 26 (7.4) 14 (6.3) 9 (5.8) 5 (8.2)
  High school graduate 106 (30.1) 97 (43.3) 72 (46.2) 21 (34.4)
  Some college 130 (36.9) 71 (31.7) 48 (30.8) 21 (34.4)
  College graduate 90 (25.6) 42 (18.8) 27 (17.3) 14 (23.0)
Follow-up
 Age at last recorded height measurement (y), mean (SD) 24.6 (5.8) 26.8 (5.0) <.001 26.8 (4.8) 26.7 (5.7) .91
 Number of height measurements per subject in 3-y age windows, median (IQR)
  Birth to <3 y 9 (7, 12) 8 (6, 12) 8 (6, 12) 8 (6, 9)
  3 to <6 y 3 (2, 6) 4 (2, 7) 4 (2, 7) 3 (2, 4)
  6 to <9 y 3 (2, 6) 4 (2, 7) 5 (3, 8) 4 (2, 6)
  9 to <12 y 4 (2, 6) 5 (3, 8) 5 (3,8) 5 (4, 7)
  12 to <15 y 4 (2, 6) 5 (3, 8) 5 (3, 8) 4 (3, 7)
  15 to <18 y 3 (1, 5) 3 (2, 6) 4 (2, 7) 3 (1, 5)
  ≥18 y 5 (1, 12) 8 (3, 18) 8 (3, 18) 9 (2, 18)
  Overall 35 (26, 49) 44 (33, 60) <.001 46 (34, 62) 41 (33, 53) .16
 Age met ADHD research criteria (y), mean (SD) n/a 10.3 (3.6) n/a 9.9 (3.4) 11.3 (3.8) .006

IQR, interquartile range.

a

Comparisons between groups were evaluated by using the χ2 test for gender, the 2-sample t test for birth length, birth wt, and age, and the Wilcoxon rank-sum test for the maternal education categories and number of height measurements.

b

Duration of stimulant treatment was unknown for 7 of the 243 ADHD cases.